- PR Newswire•last month
TORONTO, Sept. 22, 2016 /CNW/ - DELISTING REVIEW Response Biomedical Corp. (the "Company") – Further to TSX Bulletin 2016-0859 dated August 26, 2016, TSX has decided to extend its review of ...
- Marketwired•last month
Response Biomedical Corp. is pleased to announce that the Supreme Court of British Columbia has approved the previously announced acquisition of all the issued and outstanding common shares of Response ...
Response Biomedical Corp. (RBM.TO)
Toronto - Toronto Delayed Price. Currency in CAD
|Day's Range||0.96 - 0.96|
|52wk Range||0.34 - 1.20|
|1y Target Est||N/A|
|P/E Ratio (ttm)||-5.89|
|Avg Vol (3m)||2,055|
|Dividend & Yield||N/A (N/A)|